The Kidney Cancer Association presented the inaugural “Kidney Cancer Association Nicholas J. Vogelzang Humanitarian Award” to the KCA’s late co-founder and long-serving board member, Dr. Nicholas J. Vogelzang. Vogelzang, a world-renowned genitourinary oncologist specializing in…
The Kidney Cancer Association awarded seven grants to researchers pursuing projects with the potential to improve kidney cancer treatment and care.
The Kidney Cancer Association (KCA) is pleased to launch a Patient Assistance Fund (PAF) to support people with kidney cancer and relieve some of the financial burdens that accompany a diagnosis.
Seven Grants of $75,000 Each From the KCA Will Support New Kidney Cancer Research
Nicholas J. Vogelzang, MD, FACP, FASCO, a giant of genitourinary medical oncology and co-founder of the Kidney Cancer Association (KCA), will retire from his position on the KCA’s Board of Directors effective March 1, 2022. Vogelzang, 72, has served on the KCA’s board since its founding in 1990.
The Kidney Cancer Association (KCA) is pleased to announce Dr. Bradley C. Leibovich as Chairman of its Board of Directors.
The Kidney Cancer Association is pleased to announce Dr. Daniel George, a medical oncologist at the Duke Cancer Institute, is the new Chair of the KCA’s Medical Steering Committee.
The Kidney Cancer Association (KCA) presented two Advanced Discovery Awards, four Young Investigator Awards, and one Focus Award: Psychosocial to researchers who are working to uncover and refine treatment and care strategies for kidney cancer….
The Kidney Cancer Association partners with Smart Patients to create a new online kidney cancer community that will make it easier for patients and families to support and learn from one another.
New campaign to raise awareness about connection between sickle cell trait and deadly form of kidney cancer. The Kidney Cancer Association (KCA) and the Sickle Cell Disease Association of America, Inc. (SCDAA) are partnering to…
Email Radha Chitale with media inquiries. Please include your name, outlet, topic, deadline, and contact details.